Agios Pharmaceuticals

Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Agios Pharmaceuticals plus 5594 other startups.

Start Free 7 Day Trial Now

Learn More About Agios Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With